|
Early Translational IV |
Inder Verma |
Development of a cell and gene based therapy for hemophilia |
$2,298,634 |
|
Quest - Discovery Stage Research Projects |
Ronald Evans |
Extending Immune-Evasive Human Islet-Like Organoids (HILOs) Survival and Function as a Cure for T1D |
$1,523,285 |
|
Comprehensive Grant |
Fred Gage |
Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons |
$2,749,293 |
|
Basic Biology V |
Ronald Evans |
Metabolically-driven epigenetic changes in iPSC reprogramming |
$1,491,900 |
|
Early Translational I |
Inder Verma |
Curing Hematological Diseases |
$5,979,252 |
|
Disease Team Planning |
Samuel Pfaff |
Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration |
$51,266 |
|
Basic Biology II |
Ronald Evans |
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
|
Shared Labs |
Inder Verma |
Shared viral vector facility for genetic manipulation of huamn ES cell |
$1,844,315 |
|
New Faculty I |
Lei Wang |
Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons |
$2,587,742 |
|
Shared Labs |
Garry Van Gerpen |
Shared viral vector facility for genetic manipulation of huamn ES cell |
$1,478,923 |
|
Early Translational II |
Fred Gage |
Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model |
$2,472,839 |
|
Research Training II |
Juan Carlos Izpisua Belmonte |
Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II |
$2,886,221 |
|
New Faculty I |
Dana Jones |
Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity |
$2,134,100 |
|
New Cell Lines |
Fred Gage |
Development of Induced Pluripotent Stem Cells for Modeling Human Disease |
$1,737,720 |
|
Training Grant I-3 |
Juan Carlos Izpisua Belmonte |
Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies |
$1,261,333 |
|
Genomics Centers of Excellence Awards (R) |
Joseph Ecker |
Center of Excellence for Stem Cell Genomics - Salk |
$13,201,635 |
|
SEED Grant |
Beverly Emerson |
Regulation of Specific Chromosomal Boundary Elements by CTCF Protein Complexes in Human Embryonic Stem Cells |
$647,343 |
|
Early Translational III |
Juan Carlos Izpisua Belmonte |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
|
Preclinical Development Awards |
David Schubert |
Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate |
$1,664,885 |
|
SEED Grant |
Samuel Pfaff |
Gene regulatory mechanisms that control spinal neuron differentiation from hES cells. |
$704,543 |
|
Early Translational III |
David Schubert |
Stem cell based small molecule therapy for Alzheimer's disease |
$1,673,757 |
|
Quest - Discovery Stage Research Projects |
Ronald Evans |
Therapeutic immune tolerant human islet-like organoids (HILOs) for Type 1 Diabetes |
$1,637,209 |
|
SEED Grant |
Senyon Choe |
A method to maintain and propagate pluripotent human ES cells |
$760,042 |
